Skip to content

Early diagnosis and intervention for autism spectrum disorder

Early diagnosis and intervention for autism spectrum disorder based on FMRI and blood proteomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089912
Enrollment
Unknown
Registered
2024-09-19
Start date
2024-04-02
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Normal control group:None
ASD patient group:None

Sponsors

Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 8 Years

Inclusion criteria

Inclusion criteria: ASD children Group: 1) Meet the diagnostic criteria for ASD in DSM-5; 2) Aged 1-8 years old; 3) Live in Nanjing or the surrounding areas for more than 5 years (or have been living in Nanjing and the surrounding areas since birth) 4) Currently not participating in other research projects; 5) The patient's legal guardian agrees to participate in this study. Normal control group: 1) Normally developing children in the same area whose age and sex are matched with the ASD children; 2) Negative family history: (outside) grandparents, father, mother, and siblings, no ASD, developmental delay, intellectual disability, ADHD; 3) Currently not participating in other research projects; 4) The legal guardian of the child agrees to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Have a serious organic disease such as a clear history of head trauma, congenital heart disease, liver disease or liver insufficiency, kidney disease or renal insufficiency; 2) suffering from other mental illness; 3) Parents unwilling to provide relevant information and unwilling to participate in the subject; 4) There is a metal foreign body.

Design outcomes

Primary

MeasureTime frame
EEG;Behavior index;MRI images;

Countries

China

Contacts

Public ContactYingmei Lu

Nanjing Medical University, Jiangning District, Nanjing, Jiangsu Province

lufx@njmu.edu.cn+86 138 5712 6289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026